Loading
Oscar Health, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 07 Apr 2026.
Oscar Health, Inc.: what insiders have been doing
This page follows insider dealings at Oscar Health, Inc. as filed with SEC (Form 4), a company from the Healthcare & Pharma sector. The group dates from 2012. Between 18 October 2025 and 18 October 2026, 23 insiders published 99 filings.
On the market, 1 insider bought (1 purchase totalling €10.3M) while 6 insiders sold (41 sales totalling €25.6M). The totals do not cover 20 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Schlosser Mario filed the largest sale, €15.6M, on 31 August 2026, which represents 0.20% of the company's market value. Among those who bought: 1 chief executive.
The last purchase on record was published on 7 April 2026, which is 194 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
With 99 filings in twelve months, the company is more active than the median of 19 filings across the 5,808 companies we follow on the same exchange. Looking back to 2021, when coverage begins, insiders filed 12 purchases and 48 sales. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists revenue at 11.70 bn USD and net income at -443.2 m USD.
In the same sector, recent insider purchases at Cooper Companies, Inc. and Cytosorbents Corp also feature in our signals. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
272
Thresholds
n/a
Buy Volume
€37M
12 ops. · all time
Sell Volume
€71M
48 ops. · all time
Who traded when
BuySaleMario Schlosser20 sales
Bertolini Mark T1 buy8 sales
Richard Scott Blackley5 sales
Victoria Baltrus4 sales
Joshua Kushner3 buys
Thrive Partners VII Growth GP, LLC3 buys
+4 other insiders
Since the insiders bought
- +112.6%Entry US$14.64 · Close at T+90 US$31.12
- -2.1%Entry US$16.85 · Close at T+365 US$16.49
- -21.8%Entry US$18.01 · Close at T+365 US$14.08
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Oscar Health, Inc. Hold (neutral), based on 10 analysts. Average price target: US$36.40.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 11,054 of 24,148 companies
53.7
score / 100
Value45
Quality63
FCF yld10%
Earn yld-4.3%
EV/EBITDA16.4x
ROE34%
Gross mgn·
Net mgn-3.8%
Debt/EBITDA0.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$34.01
Analyst consensus
10 analystsHold
US$27.00Target US$36.40(+7%)US$49.00
Income statement
RevenueUS$11.7B
EBITDAUS$658M6% margin
Net income-US$443.2M3.6% margin
Valuation
PER (trailing)26.8x
PER (forward)15.3x
P/Book5.1x
Beta2.47
Balance sheet & cash
Market capUS$10.5B
Total debtUS$430.1M
Free Cash FlowUS$1.1B
Debt / Equity23%
Profitability & ownership
ROE34.3%
ROA4.5%
% insiders5.2%
% institutions73.5%
Last declaration on 18 September 2026
Declarations272 total
25,000 shares@ US$32.240.0090% mcap100.0% of flowClass A Common StockSEC144:0001964306-26-000450
164,218 shares0Class A Common StockSEC:0001193125-26-395853:7
6,268,097 shares0Class A Common StockSEC:0001193125-26-395847:0
75,520 shares0Class A Common StockSEC:0001193125-26-395847:1
164,218 shares0Class A Common StockSEC:0001193125-26-395847:4
1,323,589 shares0Class A Common StockSEC:0001193125-26-395847:5
4,855,810 shares0Class A Common StockSEC:0001193125-26-395847:6
1,323,589 shares0Class A Common StockSEC:0001193125-26-395847:2
4,855,810 shares0Class A Common StockSEC:0001193125-26-395847:3
164,218 shares0Class A Common StockSEC:0001193125-26-395847:7
6,268,097 shares0Class A Common StockSEC:0001193125-26-395853:0
75,520 shares0Class A Common StockSEC:0001193125-26-395853:1
1,323,589 shares0Class A Common StockSEC:0001193125-26-395853:2
4,855,810 shares0Class A Common StockSEC:0001193125-26-395853:3
164,218 shares0Class A Common StockSEC:0001193125-26-395853:4
1,323,589 shares0Class A Common StockSEC:0001193125-26-395853:5
4,855,810 shares0Class A Common StockSEC:0001193125-26-395853:6
28,869 shares@ US$31.450.010% mcap19.1% of flowClass A Common StockSEC:0001525020-26-000015:0
958 shares@ US$31.450.0003% mcap6.3% of flowClass A Common StockSEC:0001911946-26-000006:0
10,360 shares@ US$31.450.0036% mcap32.7% of flowClass A Common StockSEC:0001568651-26-000070:0
9,092 shares@ US$31.450.0031% mcap43.4% of flowClass A Common StockSEC:0001842979-26-000005:0
31,422 shares@ US$31.450.011% mcap1.9% of flowClass A Common StockSEC:0001844320-26-000018:0
28,869 shares@ US$31.45070.010% mcap19.1% of flowClass ASEC144:0001959173-26-006702
10,360 shares@ US$31.45070.0036% mcap32.7% of flowClass ASEC144:0001959173-26-006704
9,092 shares@ US$31.45070.0031% mcap43.4% of flowClass ASEC144:0001959173-26-006709
25 of 272 declarations
About Oscar Health, Inc.
Oscar Health, Inc. (NYSE: OSCR) is a U.S.-listed healthcare company headquartered in New York City, United States. Founded in 2012, Oscar was built as a technology-driven health insurer with a clear consumer focus: simplify access to care, improve the member experience, and use software and data to make insurance easier to navigate. For francophone investors, Oscar stands out less as a classic incumbent insurer and more as a digital-first healthcare platform wrapped around regulated insurance products.
Oscar’s core business is health insurance, with a particular emphasis on the ACA individual marketplace. The company also serves families, small groups, and, since 2020, Medicare Advantage members. Its product mix is anchored in medical coverage sold to consumers and employers, while its technology stack supports enrollment, customer service, care navigation, and increasingly AI-enabled tools. Oscar also positions its platform as an asset in itself, suggesting a broader ambition to leverage its operating capabilities beyond policy administration.
Read moreShow less
Competitive positioning is central to the investment case. Oscar operates in a large but highly regulated U.S. insurance market where scale, pricing discipline, medical cost management, and compliance matter as much as brand and digital experience. The company competes against major national carriers and more specialized ACA-focused insurers. Its differentiators are a user-friendly digital experience, a member-centric brand, and a technology-led operating model. At the same time, Oscar remains exposed to the typical insurance variables: claims volatility, risk adjustment dynamics, regulatory changes, and the economics of the individual marketplace.
Recent developments have been constructive on the commercial side. Oscar said it ended 2025 with a record membership base of roughly 3.4 million and entered 2026 with a sharper focus on profitability and margin expansion. In the first quarter of 2026, the company reported approximately $4.6 billion of revenue and reaffirmed its 2026 guidance. Oscar has also launched new affordable health-plan choices and AI features tied to the 2026 open enrollment cycle, while expanding into multiple U.S. markets including New Jersey, Southern Florida, Mississippi, Charlotte, and Dayton. For investors, this suggests a company that is still growth-oriented, but increasingly focused on disciplined execution and profitability. As a NYSE-listed name in the United States, Oscar combines the attributes of a regulated insurer with the optionality of a health-tech platform.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
